Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability-Reference-Cited by-同舟云学术

Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability

Published:2023-11-15 Issue:12 Volume:62 Page:1921-1930
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Backlund Ellen¹²,Grozman Vitali³⁴,Egyhazi Brage Suzanne²,Lewensohn Rolf²,Lindberg Karin¹²,Helgadottir Hildur¹²^ORCID

Affiliation:

1. Department of Oncology, Karolinska University Hospital, Stockholm, Sweden

2. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

3. Department of Diagnostic Radiology, Karolinska University Hospital, Sweden

4. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2280766

Reference37 articles.

1. Socialstyrelsen. Statistics on Cancer Incidence 2020 Socialstyrelsen: socialstyrelsen; 2021 [cited 2021 2021-12-15]. Available from: www.socialstyrelsen.se/statistik-och-data/statistik/statistikamnen/cancer/.

2. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

3. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

4. Radiation-induced tumor neoantigens: imaging and therapeutic implications;Corso CD;Am J Cancer Res,2011

5. Combination of immune checkpoint inhibitors with radiation therapy in cancer: A hammer breaking the wall of resistance

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress on Interventional Time and Safety of RT Combined with ICIs for NSCLCL;Advances in Clinical Medicine;2024